Brief: Jw (Cayman) Therapeutics Updates On New Drug Application Of Relma-Cel In China

JW (Cayman) Therapeutics Co

16/08/2021 09:27

Aug 16 (Reuters) - JW (Cayman) Therapeutics Co Ltd
 2126.HK :
    * UPDATE ON NEW DRUG APPLICATION OF RELMA-CEL IN CHINA
    * NOTES THAT NDA SUBMITTED TO NMPA RELATING TO APPROVAL OF
RELMA-CEL REMAINS UNDER REVIEW
    * SAYS  ARE NOT AWARE OF ANY MATERIAL IMPEDIMENT TO
OBTAINING
APPROVAL OF NDA FOR RELMA-CEL
    * CONTINUE TO HAVE A POSITIVE OUTLOOK ON MARKET LAUNCH OF
RELMA-CEL


Further company coverage:  2126.HK 

 ((Reuters.Briefs@thomsonreuters.com;))